BRIEF published on 02/29/2024 at 14:00, 2 years 6 months ago Alta Copper Corp. annonce des avancées majeures dans son projet Cañariaco Alta Copper Corp Cañariaco Sur Porphyre De Cuivre Et D'or Résultats Métallurgiques Evaluation Économique Préliminaire
PRESS RELEASE published on 12/20/2023 at 17:05, 2 years 8 months ago Alta Copper Announces Closing of Non-Brokered Private Placement
PRESS RELEASE published on 12/18/2023 at 22:00, 2 years 8 months ago Alta Copper Announces Non-Brokered Financing
Published on 09/11/2026 at 04:00, 4 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 17 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 35 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 48 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 20 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 45 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 1 hour 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 hour 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 20 minutes ago Availability of the 2026 Interim Financial Report
